Impact Biomedical Holds Special Shareholder Meeting
Bitget2026/11/17 21:08- Impact Biomedical shareholders approved the amended merger and share exchange agreement at a special meeting on November 13, 2026.
- Shareholders also adopted the amended and restated memorandum and articles of association.
- All eight director nominees were elected.
- The appointment of Grassi & Co. Certified Public Accountants as independent auditor was ratified for the fiscal year ending December 31, 2026.
- Adjournment was authorized if necessary, but sufficient votes to approve the proposals made it unnecessary.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Moody's: Downgrades NVIDIA outlook

Chris Vermeulen warns of deeper market selloff, sees gold falling to $3,100
Why the Unexpectedly Strong Earnings Report Couldn't Save Nvidia
Report: The European Central Bank plans to discuss raising the minimum reserve requirement from 1% to 2%
According to media reports, the European Central Bank’s Governing Council plans to discuss raising the minimum reserve requirement from the current 1% to 2% at its meeting on November 25. This move could save at least 4.4 billion euros annually for the ECB and 21 national central banks in the euro area, while also absorbing some of the excess liquidity in the system.